{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:46:01Z","timestamp":1789908361213,"version":"4.0.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Infect Dis."],"published-print":{"date-parts":[[2016,4,15]]},"DOI":"10.1093\/infdis\/jiv564","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T01:38:39Z","timestamp":1448415519000},"page":"1240-1247","source":"Crossref","is-referenced-by-count":87,"title":["L159F and V321A Sofosbuvir-Associated Hepatitis C Virus NS5B Substitutions"],"prefix":"10.1093","volume":"213","author":[{"given":"Evguenia S.","family":"Svarovskaia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Gane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Dvory-Sobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Doehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Hedskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira M.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lawitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Brainard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"McHutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"key":"2016031905424657000_213.8.1240.1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00054-12"},{"key":"2016031905424657000_213.8.1240.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60247-0"},{"key":"2016031905424657000_213.8.1240.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.11.018"},{"key":"2016031905424657000_213.8.1240.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70033-1"},{"key":"2016031905424657000_213.8.1240.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62121-2"},{"key":"2016031905424657000_213.8.1240.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316145"},{"key":"2016031905424657000_213.8.1240.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402454"},{"key":"2016031905424657000_213.8.1240.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316366"},{"key":"2016031905424657000_213.8.1240.9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00399-10"},{"key":"2016031905424657000_213.8.1240.10","doi-asserted-by":"publisher","DOI":"10.1021\/jm100863x"},{"key":"2016031905424657000_213.8.1240.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu697"},{"key":"2016031905424657000_213.8.1240.12","unstructured":"Xu S , Rajyaguru S , Chiu S et al . Sofosbuvir selects the NS5B S282T mutation in vitro in genotype 1\u20126 Replicons and is not cross-resistant to resistance-associated variants selected by other classes of antiviral inhibitors [poster 1094]. Presented at: 64th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting, Washington, DC, 1\u20135 November 2013."},{"key":"2016031905424657000_213.8.1240.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214854"},{"key":"2016031905424657000_213.8.1240.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214853"},{"key":"2016031905424657000_213.8.1240.15","doi-asserted-by":"crossref","unstructured":"Gane E , Stedman C , Garg V et al . An interferon- and ribavirin-free 12-week regimen of once-daily VX-135 and daclatasvir in treatment-na\u00efve patients with genotype 1 HCV infection. Presented at: 49th Annual Meeting of the European Association for the Study of the Liver, London, United Kingdom, 9\u201313 April 2014.","DOI":"10.1016\/S0168-8278(14)61470-7"},{"key":"2016031905424657000_213.8.1240.16","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12588"},{"key":"2016031905424657000_213.8.1240.17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27375"},{"key":"2016031905424657000_213.8.1240.18","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit562"},{"key":"2016031905424657000_213.8.1240.19","unstructured":"Han D , Strommen K , Anton ED et al . Analytical validation of an HCV replicon-based phenotypic assay for evaluating replication capacity and susceptibility of genotype 1a\/1b patient viruses to polymerase inhibitors. Presented at: International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies, Los Cabos, Mexico, 7\u201311 June 2011."},{"key":"2016031905424657000_213.8.1240.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208953"},{"key":"2016031905424657000_213.8.1240.21","unstructured":"Dvory-Sobol H , Han B , Ouyang W et al . Susceptibility of HCV genotype 1, 2, 3 and 4 baseline clinical isolates to sofosbuvir. Presented at: 21st International Symposium on Hepatitis C and Related Viruses, Banff, Canada, 7\u201311 September 2014."},{"key":"2016031905424657000_213.8.1240.22","unstructured":"Chulanov V , Zhdanov K , Kersey K et al . Sofosbuvir plus ribavirin for the treatment of Russian patients with chronic HCV genotype 1 or 3 infection. In: 65th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Massachusetts, 7\u201311 November 2014."}],"container-title":["Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/213\/8\/1240\/17411140\/jiv564.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T08:15:30Z","timestamp":1503562530000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jiv564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,3,19]]},"published-print":{"date-parts":[[2016,4,15]]}},"alternative-id":["10.1093\/infdis\/jiv564"],"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiv564","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,24]]}}}